Erschienen in:
01.02.2007 | Letter to the Editor
Infliximab-associated neuropathy in RA patients—the importance of considering the diagnosis of mononeuritis multiplex
verfasst von:
J. Birnbaum
Erschienen in:
Clinical Rheumatology
|
Ausgabe 2/2007
Einloggen, um Zugang zu erhalten
Excerpt
Accurate recognition of demyelinating syndromes affecting the peripheral and central nervous system is increasingly important in rheumatoid arthritis (RA) patients, given the association of TNF-alpha inhibitors with multiple sclerosis and demyelinating neuropathies. Tektonidou et al. report on two patients with RA developing neuropathy during treatment with Infliximab, including a patient with electrodiagnostic features reportedly consistent with a diagnosis of multifocal motor neuropathy with conduction block (MMNCB) [
1]. However, there are several clinical and electrodiagnostic features of this patient’s neuropathy, which are potentially more consistent with an axonal mononeuritis multiplex. …